Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

169 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Predictive validity of NEDA in the 16- and 21-year follow-up from the pivotal trial of interferon beta-1b.
Goodin DS, Reder AT, Traboulsee AL, Li DK, Langdon D, Cutter G, Cook S, O'Donnell T, Kremenchutzky M, Oger J, Koelbach R, Pohl C, Wicklein EM; IFNB Multiple Sclerosis Study Group and the 16- and 21-Year LTF Investigators. Goodin DS, et al. Among authors: reder at. Mult Scler. 2019 May;25(6):837-847. doi: 10.1177/1352458518773511. Epub 2018 May 15. Mult Scler. 2019. PMID: 29761737
Mechanisms of action of interferon-beta in multiple sclerosis.
Arnason BG, Dayal A, Qu ZX, Jensen MA, Genç K, Reder AT. Arnason BG, et al. Among authors: reder at. Springer Semin Immunopathol. 1996;18(1):125-48. doi: 10.1007/BF00792613. Springer Semin Immunopathol. 1996. PMID: 8984676 Review. No abstract available.
Monocyte activation in multiple sclerosis.
Reder AT, Genç K, Byskosh PV, Porrini AM. Reder AT, et al. Mult Scler. 1998 Jun;4(3):162-8. doi: 10.1177/135245859800400314. Mult Scler. 1998. PMID: 9762667
169 results